Simple Summary This manuscript is entitled “MR-LINAC, a new partner in radiation
oncology: current landscape” in response to your invitation to collaborate on the Special …

Purpose and objective To develop expert consensus statements on multiparametric dose
prescriptions for stereotactic body radiotherapy (SBRT) aligning with ICRU report 91. These …

Simple Summary RCC has traditionally been considered radioresistant, with surgery being
the gold standard for primary localized RCC. However, not all patients are suitable for …

The standard of care for non-metastatic renal cancer is surgical resection followed by
adjuvant therapy for those at high risk for recurrences. However, for older patients, surgery …

Stereotactic ablative radiotherapy (SABR) has challenged the conventional wisdom
surrounding the radioresistance of renal cell carcinoma (RCC). In the past decade, there has …

Oligometastatic RCC represents a status including a wide spectrum of clinical conditions
that requires a tailored treatment approach. The correct management integrates local …

Nuclear Medicine and Molecular Imaging, Civan et al.[1] report their findings on the role of
[68 Ga] Ga-FAPI-04 PET/CT in primary and metastatic RCC. The role of FAPI PET/CT in …

Abstract Objective To update the French recommendations for the management of kidney
cancer. Methods A systematic review of the literature was conducted for the period from …

Over the past decade, innovations in radiation technology and technique have led to the
increasing use of stereotactic body radiotherapy (SBRT) for the treatment of renal cell …

Summary Objective To update the French recommendations for the management of kidney
cancer. Methods A systematic review of the literature was conducted for the period from …